In March 2025, the company announced new programs for your immediate-to-consumer offering of its Wegovy weight loss drug. The company founded a whole new pharmacy, referred to as NovoCare, which would charge prospects $499 each month for use of the drug, below fifty percent the price of the drug by means of other pharmaceutical distribution network